<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04390490</url>
  </required_header>
  <id_info>
    <org_study_id>XH-20-007</org_study_id>
    <nct_id>NCT04390490</nct_id>
  </id_info>
  <brief_title>Clinical Trails of Photoelectrochemical Immunosensor for Early Diagnosis of Acute Myocardial Infarction</brief_title>
  <official_title>Clinical Trails of Photoelectrochemical Immunosensor for Early Diagnosis of Acute Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bin He</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective randomized controlled clinical trial will evaluate the&#xD;
      sensitivity, precision and effectiveness of photoelectrochemical immunosensor for early&#xD;
      diagosis of acute myocardial infarction.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of photoelectrochemical immunosensor</measure>
    <time_frame>28 days</time_frame>
    <description>Sensitivityï¼Œprecision and cost of the photoeletrochemical immunosensor</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Automatic chemiluminescence analyzer will be used for dectecting the concentration of cardiac troponin I as control group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Photoelectrochemical immunosensor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Photoelectrochemical immunosensor will be used for dectecting the concentration of cardiac troponin I as test group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Graphene quantum dots combined with Si nanowire photoelectrochemical immunosensor</intervention_name>
    <description>Graphene quantum dots combined with Si nanowire is a new method of photoelectrochemical immunosensor</description>
    <arm_group_label>Photoelectrochemical immunosensor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Symptoms of chest pain&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who will undergo immediate PCI Pregnant&#xD;
&#xD;
          -  Lactating women&#xD;
&#xD;
          -  Patients with mental disorders&#xD;
&#xD;
          -  Patients are using other experimental drugs; Refusal to provide informed.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bin He, PhD</last_name>
    <phone>021-25077828</phone>
    <email>hebinicu@139.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ethics Committee of Xinhua Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200092</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>May 9, 2020</study_first_submitted>
  <study_first_submitted_qc>May 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2020</study_first_posted>
  <last_update_submitted>August 12, 2020</last_update_submitted>
  <last_update_submitted_qc>August 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Bin He</investigator_full_name>
    <investigator_title>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

